showed a trendP = 0.04
Finally, circulating HbA1c levels showed a trend towards reduction between baseline and 4-week evaluation (37.6 ± 5.4 and 37.8 ± 4.2 mmol/mol, resp.) and 12 weeks after the injection (36.4 ± 5.6 mmol/mol; P = 0.04). 4.
Finally, circulating HbA1c levels showed a trend towards reduction between baseline and 4-week evaluation (37.6 ± 5.4 and 37.8 ± 4.2 mmol/mol, resp.) and 12 weeks after the injection (36.4 ± 5.6 mmol/mol; P = 0.04). 4.